Detection of preneoplasia in histologically normal prostate biopsies
- 29 June 2001
- journal article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 4 (2) , 92-96
- https://doi.org/10.1038/sj.pcan.4500500
Abstract
P2X immunolabeling of prostate detected preneoplastic changes in apparently normal tissue. Labeling occurred in two well-defined stages before the diagnostic histological markers of cancer were visible. As cancer progressed, the location of P2X expression changed from confinement within individual nuclei in the acini (stage 1) to a cytoplasmic punctate label in the acinal epithelium, with an associated removal of nuclear stain (stage 2). Finally, in advanced cases, where clear morphological evidence of cancer was apparent, the P2X label condensed exclusively on the apical epithelium (stage 3). BPH/normal tissue was entirely devoid of P2X label. Biopsy samples (77) were tested in three categories. One group (35) were diagnosed as normal benign prostatic hyperplasia (BPH) on the basis of haematoxylin and eosin (H&E) stain, although underlying disease was suspected. Of these, 14 (40%) were clearly normal and appeared entirely devoid of label, 13 (37%) exhibited the first stage of P2X receptor labeling and the remaining eight (23%) exhibited second stage labeling. The accompanying H&E-stained sections of all these cases had a normal appearance. Low grade cancer biopsy samples with Gleason scores G4-7 (25) all revealed widespread second stage receptor labeling in areas of both normal and cancerous morphology, while 17 high grade cancer biopsy samples (Gleason G8-10) all showed third stage labeling along with some residual second stage labeling. The features of each P2X labeling stage occupied the entire histological area affected, offering more opportunity to diagnose the tissue than was supplied by the more-localised diagnostic features identified by H&E-stain. Besides detecting cases of preneoplasia in biopsies with a normal H&E appearance, this technique was also able to rule out the presence of neoplasia in purely hyperplasic prostates by the absence of any P2X labeling.Prostate Cancer and Prostatic Diseases (2001) 4, 92-96Keywords
This publication has 19 references indexed in Scilit:
- Detection of Apoptotic DNA Damage in Prostate Hyperplasia Using Tyramide-amplified Avidin–HRPJournal of Molecular Histology, 1999
- Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase CJournal of Cellular Biochemistry, 1998
- Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine A1 receptor subtypes in HT29 cellsEuropean Journal of Pharmacology, 1998
- Purinergic Signalling: Pathophysiological RolesThe Japanese Journal of Pharmacology, 1998
- New perspectives on S100 proteins: a multi-functional Ca 2+ -, Zn 2+ - and Cu 2+ -binding protein familyBioMetals, 1998
- Prostate innervationThe Prostate, 1998
- Nucleotide receptors in the nervous systemMolecular Neurobiology, 1997
- Calcium signaling in prostate cancer cells: Evidence for multiple receptors and enhanced sensitivity to bombesin/GRPThe Prostate, 1997
- The concept of calcium concentration microdomains in synaptic transmissionNeuropharmacology, 1995
- Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP.Endocrinology, 1995